Pleomorphic sarcomas: subclassification, myogenic differentiation and prognosis

Published:October 06, 2008DOI:https://doi.org/10.1016/j.mpdhp.2008.08.002

      Abstract

      Pleomorphic soft tissue sarcomas (STS) in adults comprise a wide range of neoplasms which can be separated into two categories: those showing myogenic differentiation (e.g. pleomorphic leiomyosarcoma and pleomorphic rhabdomyosarcoma) and those lacking this feature (e.g. myxofibrosarcoma and extraskeletal osteosarcoma). Most are high-grade, aggressive STS, although a subset belongs to the low-grade category (e.g. myxoinflammatory fibroblastic sarcoma and pleomorphic hyalinizing angiectatic tumour). Except for dedifferentiated liposarcomas, myogenic differentiation in pleomorphic sarcomas is an adverse prognostic factor, being associated with more aggressive behaviour and higher metastatic rate. Histological subtype, large size, high tumour grade, deep situation, vascular invasion, location outside the limbs and previous history of tumour recurrence(s) are additional negative prognostic indicators. This review will focus on the salient pathological, molecular and prognostic characteristics of the most common myogenic and non-myogenic pleomorphic STS.

      Keywords

      To read this article in full you will need to make a payment

      References

      1. Fletcher C.D.M. Unni K.K. Mertens F. World Health Organization classification of tumours. Pathology and genetics of tumors of soft tissue and bone. IARC Press, Lyon2002
      2. Weiss S.W. Goldblum J.R. Enzinger and Weiss’s soft tissue tumors. 5th edn. Mosby-Elsevier, St Louis2008
        • Fletcher C.D.
        Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma.
        Am J Surg Pathol. 1992; 16: 213-228
        • Fletcher C.D.M.
        The evolving classification of soft tissue tumours: an update based on the new WHO classification.
        Histopathology. 2006; 48: 3-12
        • Dei Tos A.P.
        Classification of pleomorphic sarcomas: where are we now?.
        Histopathology. 2006; 48: 51-62
        • O’Brien J.E.
        • Stout A.P.
        Malignant fibrous xanthomas.
        Cancer. 1964; 17: 1445-1455
        • Kempson R.L.
        • Kyriakos M.
        Fibroxanthosarcoma of the soft tissues: a type of malignant fibrous histiocytoma.
        Cancer. 1972; 29: 961-976
        • Weiss S.W.
        • Enzinger F.M.
        Malignant fibrous histiocytoma: an analysis of 200 cases.
        Cancer. 1978; 41: 2250-2266
        • Weiss S.W.
        Malignant fibrous histiocytoma: a reaffirmation.
        Am J Surg Pathol. 1982; 6: 773-784
        • Nielsen T.O.
        Microarray analysis of sarcomas.
        Adv Anat Pathol. 2006; 13: 166-173
        • Nakayama R.
        • Nemoto T.
        • Takahashi H.
        • et al.
        Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma.
        Mod Pathol. 2007; 20: 749-759
        • Coindre J.M.
        • Hostein I.
        • Maire G.
        • et al.
        Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histologic review, genomic profile, and MDM2 and CDK4 status favour a single entity.
        J Pathol. 2004; 203: 822-830
        • Coindre J.M.C.
        • Mariani O.
        • Chibon F.
        • et al.
        Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma.
        Mod Pathol. 2003; 16: 256-262
        • Miettinen M.
        • Fetsch J.F.
        Evaluation of biological potential of smooth muscle tumours.
        Histopathology. 2006; 48: 97-105
        • Merchant W.
        • Calonje E.
        • Fletcher C.D.M.
        Inflammatory leiomyosarcoma: a morphological subgroup within the heterogeneous family of so- called inflammatory malignant fibrous histiocytoma.
        Histopathology. 1995; 27: 525-532
        • Mentzel T.
        • Calonje E.
        • Fletcher C.D.M.
        Leiomyosarcoma with prominent osteoclast-like giant cells. Analysis of eight cases closely mimicking the so-called giant cell variant of malignant fibrous histiocytoma.
        Am J Surg Pathol. 1994; 18: 258-265
        • Lee Y.F.
        • John M.
        • Falconer A.
        • et al.
        A gene expression signature associated with metastatic outcome in human leiomyosarcomas.
        Cancer Res. 2004; 64: 7201-7204
        • Ren B.
        • Yu Y.P.
        • Jing L.
        • et al.
        Gene expression analysis of human soft tissue leiomyosarcomas.
        Hum Pathol. 2003; 34: 549-558
        • Suehara Y.
        • Kondo T.
        • Fujii K.
        • et al.
        Proteomic signatures corresponding to histological classification and grading of soft-tissue sarcomas.
        Proteomics. 2006; 6: 4402-4409
      3. Pérot G, Derré J, Coindre JM, et al. Myocardin amplification and overexpression induce a strong smooth muscle differentiation in retroperitoneal leiomyosarcomas, in press.

        • Furlong M.A.
        • Mentzel T.
        • Fanburg-Smith J.C.
        Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers.
        Mod Pathol. 2001; 14: 595-603
        • Little D.J.
        • Ballo M.T.
        • Zagars G.K.
        • et al.
        Adult rhabdomyosarcoma. Outcome following multimodality treatment.
        Cancer. 2002; 95: 377-388
        • Henricks W.H.
        • Chu Y.C.
        • Goldblum J.R.
        • Weiss S.W.
        Dedifferentiated liposarcoma. A clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation.
        Am J Surg Pathol. 1997; 21: 271-281
        • McCormick D.
        • Mentzel T.
        • Beham A.
        • Fletcher C.D.M.
        Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas.
        Am J Surg Pathol. 1994; 18: 1213-1223
        • Huang H.Y.
        • Brennan M.F.
        • Singer S.
        • Antonescu C.R.
        Distant metastasis in retroperitoneal dedifferentiated liposarcoma is rare and rapidly fatal: a clinicopathological study with emphasis on the low-grade myxofibrosarcoma-like pattern as an early sign of dedifferentiation.
        Mod Pathol. 2005; 18: 976-984
        • Bui Nguyen Binh M.
        • Guillou L.
        • Hostein I.
        • et al.
        Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk. A study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas.
        Am J Surg Pathol. 2007; 31: 1557-1566
        • Binh M.B.
        • Sastre-Garau X.
        • Guillou L.
        • et al.
        MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: A comparative analysis of 559 soft tissue neoplasms with genetic data.
        Am J Surg Pathol. 2005; 29: 1340-1347
        • Sirvent N.
        • Coindre J.M.
        • Maire G.
        • et al.
        Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization (FISH) in 200 paraffin-embedded tumor samples: utility in the differential diagnostic approach of adipocytic lesions and comparison with immunohistochemistry and real time PCR.
        Am J Surg Pathol. 2007; 31: 1476-1489
        • Sandberg A.A.
        Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma.
        Cancer Genet Cytogenet. 2004; 155: 1-24
        • Chibon F.
        • Mariani O.
        • Derre J.
        • et al.
        ASK1 (MAP3K5) as a potential therapeutic target in malignant fibrous histiocytomas with 12q14- q15 and 6q23 amplifications.
        Genes Chromosomes Cancer. 2004; 40: 32-37
        • Mariani O.
        • Brennetot C.
        • Coindre J.M.
        • et al.
        JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas.
        Cancer Cell. 2007; 11: 361-374
        • Gebhard S.
        • Coindre J.M.
        • Michels J.J.
        • et al.
        Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases. A study from the French Federation of Cancer Centers Sarcoma Group.
        Am J Surg Pathol. 2002; 26: 601-616
        • Hornick J.L.
        • Bosenberg M.W.
        • Mentzel T.
        • McMenamin M.E.
        • Oliveira A.M.
        • Fletcher C.D.M.
        Plemorphic liposarcoma. Clinicopathologic analysis of 57 cases.
        Am J Surg Pathol. 2004; 28: 1257-1267
        • Dei Tos A.P.
        • Mentzel T.
        • Fletcher C.D.M.
        Primary liposarcoma of the skin: a rare neoplasm with unusual high grade features.
        Am J Dermatopathol. 1998; 20: 332-338
        • Miettinen M.
        • Enzinger F.M.
        Epithelioid variant of pleomorphic liposarcoma: a study of 12 cases of a distinctive variant of high-grade liposarcoma.
        Mod Pathol. 1999; 12: 722-728
        • Merck C.
        • Angervall L.
        • Kindblom L.G.
        • Oden A.
        Myxofibrosarcoma. A malignant soft tissue tumor of fibroblastic-histiocytic origin. A clinicopathologic and prognostic study of 110 cases using multivariate analysis.
        Acta Pathol Microbiol Immunol Scand. 1983; 282: 1-40
        • Mentzel T.
        • Calonje E.
        • Wadden C.
        • et al.
        Myxofibrosarcoma: clinicopathologic analysis of 75 cases with emphasis on the low grade variant.
        Am J Surg Pathol. 1996; 20: 391-405
        • Huang H.Y.
        • Lal P.
        • Qin J.
        • Brennan M.F.
        • Antonescu C.R.
        Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems.
        Hum Pathol. 2004; 35: 612-621
      4. 39a
        • Lin C.N.
        • Chou S.C.
        • Li C.F.
        • et al.
        Prognostic factors of myxofibrosarcomas: implications of margin status, tumor necrosis, and mitotic rate on survival.
        J Surg Oncol. 2006; 93: 294-303
      5. 39b
        • Nascimento A.F.
        • Bertoni F.
        • Fletcher C.D.M.
        Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases.
        Am J Surg Pathol. 2007; 31: 99-105
        • Montgomery E.
        • Fisher C.
        Myofibroblastic differentiation in malignant fibrous histiocytoma (pleomorphic myofibrosarcoma): a clinicopathological study.
        Histopathology. 2001; 38: 499-509
        • Fisher C.
        Myofibrosarcoma.
        Virchows Arch. 2004; 445: 215-223
        • Smith M.E.F.
        • Fisher C.
        • Weiss S.W.
        Pleomorphic hyalinizing angiectatic tumor of soft parts. A low-grade neoplasm resembling neurilemoma.
        Am J Surg Pathol. 1996; 20: 21-29
        • Folpe A.L.
        • Weiss S.W.
        Pleomorphic hyalinizing angiectatic tumor. Analysis of 41 cases supportring evolution from a distinctive precursor lesion.
        Am J Surg Pathol. 2004; 28: 1417-1425
        • Montgomery E.A.
        • Devaney K.O.
        • Giordano T.J.
        • Weiss S.W.
        Inflammatory myxohyaline tumor of distal extremities with virocyte or Reed-Sternberg-like cells: a distinctive lesion with features simulating inflammatory conditions, Hodgkin’s disease, and various sarcomas.
        Mod Pathol. 1998; 11: 384-391
        • Meis-Kindblom J.M.
        • Kindblom L.G.
        Acral myxoinflammatory fibroblastic sarcoma: a low-grade tumor of the hands and feet.
        Am J Surg Pathol. 1998; 22: 911-924
        • Fletcher C.D.
        • Gustafson P.
        • Rydholm A.
        • et al.
        Clinicopathologic re- evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification.
        J Clin Oncol. 2001; 19: 3045-3050
        • Deyrup A.T.
        • Haydon R.C.
        • Huo D.
        • et al.
        Myoid differentiation and prognosis in adult pleomorphic sarcomas of the extremity: an analysis of 92 cases.
        Cancer. 2003; 98: 805-813